Ibogaine vs. Iboga Alkaloids for Treating Addiction
Novel chemical variants of ibogaine may offer therapeutic benefits without severe side effects.
Biology
Editor’s Choice Award – Best Study on Psychedelics and Nature 2020
This influential study advances the understanding of magic mushroom physiology and helps answer several fundamental questions.
Numinus Legally Cultivates Magic Mushrooms Under License from Health Canada
This is the first time since the 1970s that a Canadian company has legally cultivated and harvested psychedelic mushrooms.
Cultivating Psilocybe cubensis: Suitable Substrates
From cow dung to coffee grounds. this species grows well on a variety of substrates.
LSD, Music, and the Mysteries of Consciousness
Connectome-Specific Harmonic Waves: A new way of looking at the brain sheds light on the biological correlates of consciousness.
Cybin’s Sublingual Psilocybin Strips Head to Clinical Trials for Dose-Finding
The first trial will determine the sublingual dose equivalent to 25 mg psilocybin administered orally.
Cultivating P. cubensis: Light and Tryptamine Are Key for Controlling Psilocybin and Psilocin Levels
No light and increasing tryptamine in the growing medium leads to more psilocin but less psilocybin in the mushrooms.
Metabolizing DMT – The Differences Between Oral Administration and Smoking
Research is indicating that a less efficient metabolic pathway plays a role in DMT’s psychoactivity.
Get to Know the Beta Carbolines – Newcomers to the Science of Magic Mushrooms
Understanding the pharmacology of magic mushrooms is not just about tryptamines anymore.
Using Zebrafish as an Experimental Model in Psychedelic Research
These creatures have more in common with humans than one might suspect.